Research published in the Journal of the American Medical Association finds that the onset of Part D prescription drug coverage helped reduce relative non-drug spending for those beneficiaries who previously…
Read More
Our current Potpourri contains nuggets on use of robotic surgery for prostate cancer, the effect of mandated rebates in Medicare Part D on patient costs, FDA guidance on device modifications,…
Read More
The dog days of summer bring yet another scorching hot Potpourri with a smorgasbord of data, including metabias in randomized clinical trials, the practice of defensive medicine, the status of…
Read More
Our final drug report post discusses releases from Express Scripts, the Pharmacy Benefit Management Institute and ESI's PMSI division, which focuses on workers' compensation pharmacy. Express Scripts emphasizes behavioral aspects…
Read More
Today's drug trend reports come from Medco and CVS Caremark, two of the largest pharmacy benefit managers. Both experienced relatively low overall trends and both anticipate specialty drug management being…
Read More
Our next set of drug reports deals with specialty drugs, the most expensive and fastest growing category, and one which has bedeviled payers but many of the drugs are covered…
Read More
The first analysis of a weeklong series on recent reports related to aspects of the pharmaceutical industry covers IMS' report giving projections on aspects of global drug use and spending…
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts